Difference between revisions of "Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5 (Q9578)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2012, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Hematol. Am. Soc. Hematol. Educ. Program, #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Hematol. Am. Soc. Hematol. Educ. Program | ||
| Property / Published In Name String: Hematol. Am. Soc. Hematol. Educ. Program / rank | |||
| + | Normal rank | ||
Revision as of 20:36, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kiladjian JJ
0 references
2012
0 references
Hematol. Am. Soc. Hematol. Educ. Program
0 references
